Literature DB >> 23383752

High yield production of a soluble bifidobacterial β-galactosidase (BbgIV) in E. coli DH5α with improved catalytic efficiency for the synthesis of prebiotic galactooligosaccharides.

Ali Osman1, George Tzortzis, Robert A Rastall, Dimitris Charalampopoulos.   

Abstract

The bifidobacterial β-galactosidase (BbgIV) was produced in E. coli DH5α at 37 and 30 °C in a 5 L bioreactor under varied conditions of dissolved oxygen (dO2) and pH. The yield of soluble BbgIV was significantly (P < 0.05) increased once the dO2 dropped to 0-2% and remained at such low values during the exponential phase. Limited dO2 significantly (P < 0.05) increased the plasmid copy number and decreased the cells growth rate. Consequently, the BbgIV yield increased to its maximum (71-75 mg per g dry cell weight), which represented 20-25% of the total soluble proteins in the cells. In addition, the specific activity and catalytic efficiency of BbgIV were significantly (P < 0.05) enhanced under limited dO2 conditions. This was concomitant with a change in the enzyme secondary structure, suggesting a link between the enzyme structure and function. The knowledge generated from this work is very important for producing BbgIV as a biocatalyst for the development of a cost-effective process for the synthesis of prebiotic galactooligosaccharides from lactose.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23383752     DOI: 10.1021/jf304792g

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

Review 1.  Potential applications of recombinant bifidobacterial proteins in the food industry, biomedicine, process innovation and glycobiology.

Authors:  José A Morales-Contreras; Jessica E Rodríguez-Pérez; Carlos A Álvarez-González; Mirian C Martínez-López; Isela E Juárez-Rojop; Ángela Ávila-Fernández
Journal:  Food Sci Biotechnol       Date:  2021-08-03       Impact factor: 3.231

2.  Two β-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides.

Authors:  Sheryl Lozel Arreola; Montira Intanon; Jasmina Suljic; Roman Kittl; Ngoc Hung Pham; Paul Kosma; Dietmar Haltrich; Thu-Ha Nguyen
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.